Generated by AI
Profound Medical Corp. is a commercial-stage medical device company focused on developing and marketing incision-free therapeutic systems for image-guided ablation of diseased tissue. Its flagship TULSA-PRO system combines real-time MRI, AI-assisted planning, robotically driven transurethral ultrasound, and closed-loop temperature control to treat prostate tissue with precision. The company also offers Sonalleve, an MRI-guided focused ultrasound platform designed for noninvasive treatment of diseased tissue. Profound Medical Corp. serves hospitals and specialty medical centers that use its technologies in urology and other therapeutic applications, with a business model centered on device sales, associated disposable components, and clinical support services. Headquartered in Mississauga, Canada, Profound Medical Corp. plays a niche role in the medical technology market by providing minimally invasive alternatives that integrate with existing imaging infrastructure.
Website2400 Skymark Avenue
Mississauga, ON, L4W 5K5
Canada
The latest articles about PROF.
Profound Medical Corp (PROF) posted strong Q3 2026 revenue growth and margin expansion while extending its cash runway, even as it navigates rising operating costs and a leadership transition.
Profound Medical expands U.S. TULSA-PRO sales via Cook Medical, boosting installed base and recurring revenue potential.
Summary of Oct 8's posts. Generated by AI.
No summary yet.
No summary yet.
No summary yet.
Summary of Oct 8's posts. Generated by AI.
Investors talking about PROF also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.